| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.62▼ | 9.62▼ | 9.64▼ | 9.84▼ | 9.44▲ |
| MA10 | 9.63▼ | 9.65▼ | 9.64▼ | 9.80▼ | 8.72▲ |
| MA20 | 9.61▲ | 9.64▼ | 9.76▼ | 9.27▲ | 7.72▲ |
| MA50 | 9.65▼ | 9.89▼ | 9.95▼ | 8.30▲ | 9.93▼ |
| MA100 | 9.65▼ | 9.94▼ | 9.62▼ | 7.44▲ | 7.67▲ |
| MA200 | 9.73▼ | 9.52▲ | 8.99▲ | 9.61▲ | 5.69▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | 0.008▲ | -0.006▼ | -0.027▼ | 0.419▲ |
| RSI | 47.372▼ | 41.980▼ | 40.874▼ | 59.089▲ | 56.893▲ |
| STOCH | 33.799 | 27.327 | 49.480 | 52.308 | 82.745▲ |
| WILL %R | -73.913 | -61.728 | -64.545 | -44.138 | -20.938▲ |
| CCI | -43.411 | -54.596 | -11.194 | 5.128 | 105.552▲ |
|
Friday, June 20, 2025 01:12 PM
Wave Life Sciences presented preclinical data on WVE-007, a potential obesity treatment, showing weight loss and reduced inflammation.
|
|
Wednesday, April 23, 2025 05:00 PM
Fintel reports that on April 29, 2025, Cantor Fitzgerald initiated coverage of Wave Life Sciences (NasdaqGM:WVE) with a Overweight recommendation.
|
|
Wednesday, March 19, 2025 05:00 PM
CHRISTIAN O HENRY, a director at $WVE, sold 10,500 shares of the company on 03-20-2025 for an estimated $102,574. We received data on the trade from a recent SEC filing.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/09/25 | 9.57 | 9.865 | 9.55 | 9.615 | 1,069,433 |
| 29/08/25 | 9.89 | 10.06 | 9.43 | 9.60 | 1,194,139 |
| 28/08/25 | 10.13 | 10.44 | 9.90 | 9.93 | 1,476,678 |
| 27/08/25 | 9.885 | 10.415 | 9.87 | 10.08 | 1,422,690 |
| 26/08/25 | 9.97 | 10.17 | 9.84 | 9.97 | 1,744,417 |
| 25/08/25 | 10.04 | 10.16 | 9.83 | 9.94 | 1,468,474 |
| 22/08/25 | 9.85 | 10.575 | 9.72 | 10.15 | 2,081,510 |
| 21/08/25 | 9.41 | 9.92 | 9.38 | 9.76 | 884,796 |
| 20/08/25 | 9.50 | 9.56 | 9.30 | 9.45 | 1,163,468 |
| 19/08/25 | 9.77 | 9.83 | 9.26 | 9.51 | 1,691,300 |
|
|
||||
|
|
||||
|
|